Arvinas (ARVN) Non-Current Deferred Revenue (2017 - 2026)
Arvinas (ARVN) recorded Non-Current Deferred Revenue of $138.2 million in Q1 2026, up 16.7% from $118.4 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas reported Non-Current Deferred Revenue of $134.3 million, down 54.0% from FY2024.
- Annual Non-Current Deferred Revenue has declined for four straight years, though with a five-year compound annual growth rate of 42.4% (FY2020 to FY2025).
- Across earlier years, Non-Current Deferred Revenue came in at $292 million in FY2024 (-24.4%), $386.2 million in FY2023 (-4.7%), $405.1 million in FY2022 (-24.2%) and $534.3 million in FY2021.
- The Q1 2026 figure is the highest quarterly Non-Current Deferred Revenue since Q4 2024.
- On a year-over-year basis, Non-Current Deferred Revenue rose in three of the last eight quarters, with an average decline of 29.0%.
- Peak year-over-year performance for Non-Current Deferred Revenue in the last five years was growth of 16.7% in Q1 2026, against a decline of 67.2% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $134.3 million (Q4 2025), $127.4 million (Q3 2025) and $134.1 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 138.20 Mn |
| Dec 31, 2025 | 134.30 Mn |
| Sep 30, 2025 | 127.40 Mn |
| Jun 30, 2025 | 134.10 Mn |
| Mar 31, 2025 | 118.40 Mn |
| Dec 31, 2024 | 292.00 Mn |
| Sep 30, 2024 | 304.50 Mn |
| Jun 30, 2024 | 331.30 Mn |
| Mar 31, 2024 | 361.00 Mn |
| Dec 31, 2023 | 386.20 Mn |
| Sep 30, 2023 | 281.90 Mn |
| Jun 30, 2023 | 310.50 Mn |
| Mar 31, 2023 | 378.90 Mn |
| Dec 31, 2022 | 405.10 Mn |
| Sep 30, 2022 | 464.60 Mn |
| Jun 30, 2022 | 493.60 Mn |
| Mar 31, 2022 | 521.90 Mn |
| Dec 31, 2021 | 534.30 Mn |
| Sep 30, 2021 | 600.43 Mn |
| Jun 30, 2021 | 14.86 Mn |
API Access
Arvinas Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();